Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients with Diarrhea-Predominant Irritable Bowel Syndrome

Journal of Parenteral and Enteral Nutrition

Volumn 40, Issue 8, 2016, Pages 1170-1176

  Bertrand, Julien ^a,b   Ghouzali, Ibtissem ^a,b   Guérin, Charlène ^a,b   Bôle Feysot, Christine ^a,b   Gouteux, Mélodie ^a,b   Déchelotte, Pierre ^a,b,c   Ducrotté, Philippe ^a,c   Coëffier, Moïse ^a,b,c  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITY OF ROUEN   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

claudin; diarrhea; glutamine; irritable bowel syndrome; occludin; tight junctions

Indexed keywords

CLAUDIN 1; GLUTAMINE; OCCLUDIN; TIGHT JUNCTION PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CULTURE MEDIUM; CYTOKINE PRODUCTION; DIARRHEA; DRUG EFFECT; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INCUBATION TIME; INTESTINE MUCOSA PERMEABILITY; IRRITABLE COLON; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PERMEABILITY;

ADULT; CLAUDIN-1; DIARRHEA; FEMALE; GLUTAMINE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; OCCLUDIN; PERMEABILITY;

EID: 84995387494     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115587330     Document Type: Article

References (37)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC,. Functional bowel disorders. Gastroenterology. 2006; 130: 1480-1491.
2. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA,. Functional bowel disorders and functional abdominal pain. Gut. 1999; 45 (suppl 2): II43-II47.
3. Drossman DA, Camilleri M, Mayer EA, Whitehead WE,. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002; 123: 2108-2131.
4. Zhou Q, Souba WW, Croce CM, Verne GN,. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut. 2010; 59: 775-784.
5. Zhou Q, Zhang B, Verne GN,. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain. 2009; 146: 41-46.
6. Bertiaux-Vandaele N, Beutheu Youmba S, et al. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype. Am J Gastroenterol. 2011; 166: 2165-2173.
7. Coeffier M, Gloro R, Boukhettala N, et al. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am J Gastroenterol. 2010; 105: 1181-1188.
8. Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009; 58: 196-201.
9. Martinez C, Vicario M, Ramos L, et al. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol. 2012; 107: 736-746.
10. Sido B, Seel C, Hochlehnert A, Breitkreutz R, Droge W,. Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation? Dig Dis Sci. 2006; 51: 2170-2179.
11. De-Souza DA, Greene LJ,. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005; 33: 1125-1135.
12. Boukhettala N, Claeyssens S, Bensifi M, et al. Effects of essential amino acids or glutamine deprivation on intestinal permeability and protein synthesis in HCT-8 cells: involvement of GCN2 and mTOR pathways. Amino Acids. 2012; 42: 375-383.
13. Le Bacquer O, Laboisse C, Darmaun D,. Glutamine preserves protein synthesis and paracellular permeability in Caco-2 cells submitted to "luminal fasting." Am J Physiol Gastrointest Liver Physiol. 2003; 285: G128-G136.
14. Li N, Lewis P, Samuelson D, Liboni K, Neu J,. Glutamine regulates Caco-2 cell tight junction proteins. Am J Physiol Gastrointest Liver Physiol. 2004; 287: G726-G733.
15. Beutheu S, Ghouzali I, Galas L, Dechelotte P, Coeffier M,. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells. Clin Nutr. 2013; 32: 863-869.
16. Beutheu S, Ouelaa W, Guerin C, et al. Glutamine supplementation, but not combined glutamine and arginine supplementation, improves gut barrier function during chemotherapy-induced intestinal mucositis in rats. Clin Nutr. 2014; 33: 694-701.
17. Choi K, Lee SS, Oh SJ, et al. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Clin Nutr. 2007; 26: 57-62.
18. Daniele B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut. 2001; 48: 28-33.
19. Coeffier M, Dechelotte P, Ducrotte P,. Intestinal permeability in patients with diarrhea predominant irritable bowel syndrome: is there a place for glutamine supplementation? Gastroenterology. 2015; 148 (5): 1079-1080.
20. Coeffier M, Marion R, Ducrotte P, Dechelotte P,. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin Nutr. 2003; 22: 407-413.
21. Belmonte L, Beutheu Youmba S, Bertiaux-Vandaele N, et al. Role of Toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One. 2012; 7: e42777.
22. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254.
23. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006; 101: 1288-1294.
24. Zhou Q, Costinean S, Croce CM, et al. MicroRNA 29 targets nuclear factor-kappaB-repressing factor and claudin 1 to increase intestinal permeability. Gastroenterology. 2015; 148: 158-169.e8.
25. Smith MW, James PS,. Amino acid transport by the helicoidal colon of the new-born pig. Biochim Biophys Acta. 1976; 419: 391-394.
26. Blachier F, Boutry C, Bos C, Tome D,. Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines. Am J Clin Nutr. 2009; 90: 814S-821S.
27. Bertrand J, Marion-Letellier R, et al. Glutamine enema regulates colonic ubiquitinated-proteins but not proteasome activities during TNBS-induced colitis leading to increased mitochondrial activity. [published online 17, 2015 ]. Proteomics.
28. Kretzmann NA, Fillmann H, Mauriz JL, et al. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis. 2008; 14: 1504-1513.
29. Wischmeyer P, Pemberton JH, Phillips SF,. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc. 1993; 68: 978-981.
30. Coeffier M, Marion-Letellier R, Dechelotte P,. Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm Bowel Dis. 2010; 16: 518-524.
31. Darcy-Vrillon B, Morel MT, Cherbuy C, et al. Metabolic characteristics of pig colonocytes after adaptation to a high fiber diet. J Nutr. 1993; 123: 234-243.
32. Vermeulen MA, de Jong J, Vaessen MJ, van Leeuwen PA, Houdijk AP,. Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity. World J Gastroenterol. 2011; 17: 1569-1573.
33. Seth A, Basuroy S, Sheth P, Rao RK,. L-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer. Am J Physiol Gastrointest Liver Physiol. 2004; 287: G510-G517.
34. Barbara G, Stanghellini V, De Giorgio R, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004; 126: 693-702.
35. Barkhordari E, Rezaei N, Mahmoudi M, et al. T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation. 2010; 33: 281-286.
36. O'Loughlin EV, Pang GP, Noltorp R, Koina C, Batey R, Clancy R,. Interleukin 2 modulates ion secretion and cell proliferation in cultured human small intestinal enterocytes. Gut. 2001; 49: 636-643.
37. Epple HJ, Schneider T, Troeger H, et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut. 2009; 58: 220-227.